Source: Virtual Congress 2021 – Bronchiectasis and pleural infection



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Chen (Nan ning, China), H. Cheng (Shen Zhen, China), Z. Cai (Shen Zhen, China), Q. Wei (Nan ning, China), J. Li (Nan ning, China), J. Liang (Nan ning, China), W. Zhang (Nan ning, China), Z. Yu (Shen Zhen, China), D. Liu (Shen Zhen, China), L. Liu (Shen Zhen, China), Z. Zhang (Liu Zhou, China), W. Ke (Nan ning, China), L. Yang (Shen Zhen, China). Identification of microbiome etiology associated with drug resistance in pleural empyema. 2019

Member's Comments

No comment yet.

Related content which might interest you: Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens Source: Eur Respir Rev, 28 (152) 190041; 10.1183/16000617.0041-2019 Year: 2019 Bacterial aetiology in the Danish pleural empyema project Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Malignant pleural effusion related empyema — etiology, pathogen, and management Source: Annual Congress 2009 - Pleural and mediastinal diseases Year: 2009 Major pitfalls in pleural empyema: what about the underlying disease?  Source: International Congress 2016 – An update on pleural empyema diagnostics and treatment Year: 2016 Co-occurrence analysis relates a macrolide resistome to the pulmonary microbiome in chronic respiratory disease Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020 The new method for diagnosis of pleural effusion of unknown etiology Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I Year: 2008 Spontaneous bacterial empyema in cirrhotic patients: pathogenic mechanisms and diagnostic tools Source: Eur Respir J 2006; 28: Suppl. 50, 50s Year: 2006 Advances in pleural infection and malignancy Source: Eur Respir Rev, 30 (159) 200002; 10.1183/16000617.0002-2020 Year: 2021 Patterns of the infections associated with lung and pleural malignancies Source: Eur Respir J 2003; 22: Suppl. 45, 63s Year: 2003 Predictive factors, microbiology and outcome of patients with parapneumonic effusion Source: Eur Respir J 2011; 38: 1173-1179 Year: 2011 Antibiotic resistance in pulmonary infections: mechanisms and epidemiology Source: Eur Respir Monogr 2017; 75: 21-43 Year: 2017 Management of pleural infection Source: Short video discussion 2021 Year: 2021 Ultrasound diagnostics of exudative plurisy among patients with pulmonary tuberculosis with drug resistance Source: Eur Respir J 2004; 24: Suppl. 48, 427s Year: 2004 Efficacy of diagnostics to pleural effusions of unknown etiology during TB epidemic in Ukraine Source: Eur Respir J 2005; 26: Suppl. 49, 414s Year: 2005 The etiology and antimicrobial drugs resistance of microorganisms in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 2s Year: 2006 The role of CTPA in investigating a patient with a pleural effusion of unknown etiology Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status Year: 2021 Long-term use of inhaled corticoids on the development of pleural effusion in community-acquired pneumonia Source: Annual Congress 2012 - Hot topics in respiratory infections Year: 2012 Pleural infection and empyema Source: Annual Congress 2012 - PG16 ERS/ACCP joint course on diagnostic and management strategies for pleural disorders Year: 2012 Identification and management of non tuberculous mycobacteria in extra pulmonary cases in clinical practice Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections Year: 2009 Genetic homology between bacteria in pus from the pyothorax and bacteria in the oral cavity in patients with pyothorax Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016